Critical Raw Materials Act (Proposed Regulation COM(2023) 192) for Healthcare
Hospitals, pharmaceutical companies, medical device manufacturers, health insurers, and clinical research organisations face some of the strictest compliance requirements globally. Here is how Critical Raw Materials Act (Proposed Regulation COM(2023) 192) helps healthcare organisations build and maintain compliance.
Why Critical Raw Materials Act (Proposed Regulation COM(2023) 192) Matters for Healthcare
Hospitals, pharmaceutical companies, medical device manufacturers, health insurers, and clinical research organisations face some of the strictest compliance requirements globally. Patient data protection, clinical trial integrity, and medical device safety demand rigorous governance frameworks.
Healthcare organisations typically navigate HIPAA, FDA regulations, GxP requirements, and regional data protection laws simultaneously. A structured compliance framework helps consolidate these overlapping obligations into a manageable programme.
Critical Raw Materials Act (Proposed Regulation COM(2023) 192) provides 22 controls organised across 8 domains that can be mapped to healthcare-specific regulatory requirements. This structured approach helps organisations avoid compliance gaps while reducing the overhead of managing multiple overlapping obligations.
Healthcare Compliance Challenges
Healthcare organisations implementing Critical Raw Materials Act (Proposed Regulation COM(2023) 192) commonly face these challenges:
Protecting electronic health records (EHR) and patient data across distributed systems
Meeting multiple overlapping regulations (HIPAA, FDA 21 CFR, GxP, GDPR for clinical trials)
Securing connected medical devices and IoT endpoints in clinical environments
Managing third-party vendor risk across supply chains for pharmaceuticals and devices
Balancing rapid digital health innovation with data protection requirements
Implementation Approach for Healthcare
1. Assess Current State
Conduct a readiness assessment against Critical Raw Materials Act (Proposed Regulation COM(2023) 192) to identify gaps specific to your healthcare environment. Our AI-powered assessment takes 5 minutes and produces a prioritised action plan.
2. Map Regulatory Overlap
Use cross-framework mapping to identify where Critical Raw Materials Act (Proposed Regulation COM(2023) 192) controls satisfy other healthcare regulations. This reduces duplicate effort and accelerates compliance.
3. Implement Priority Controls
Focus on high-risk gaps first, using healthcare-specific threat intelligence to prioritise controls that address your most material risks.
4. Monitor & Improve
Establish continuous monitoring and regular reassessment cycles. Healthcare regulations evolve frequently, so compliance is an ongoing programme, not a one-time project.
Critical Raw Materials Act (Proposed Regulation COM(2023) 192) in Healthcare by Role
Critical Raw Materials Act (Proposed Regulation COM(2023) 192) in Other Industries
Frequently Asked Questions
Why is Critical Raw Materials Act (Proposed Regulation COM(2023) 192) important for Healthcare?
How do Healthcare organisations implement Critical Raw Materials Act (Proposed Regulation COM(2023) 192)?
What are the biggest Critical Raw Materials Act (Proposed Regulation COM(2023) 192) compliance challenges in Healthcare?
Does Critical Raw Materials Act (Proposed Regulation COM(2023) 192) satisfy Healthcare regulatory requirements?
How long does Critical Raw Materials Act (Proposed Regulation COM(2023) 192) implementation take in Healthcare?
How ready is your Healthcare organisation for Critical Raw Materials Act (Proposed Regulation COM(2023) 192)?
Answer 25 questions and get a professional readiness report with gap analysis, maturity scores, and prioritised action items tailored to healthcare. Results in 5 minutes.